Search results for "k-bio"

U.S. and EU Escalate Pressure on China: A Turning Point for K-Bio?

U.S. and EU Escalate Pressure on China: A Turning Point for K-Bio?

As the United States prepares to announce the initial regulatory targets of the Biosecurity Act this week, market analysts suggest that the inclusion...
K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval

K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval

South Korean pharmaceutical and biotech companies are aggressively pursuing product approvals and clinical trials with the U. S.
K-Toxins Heading to China... Will Hugel Be Followed After 5 Years in the Top 3?

K-Toxins Heading to China... Will Hugel Be Followed After 5 Years in the Top 3?

Domestic botulinum toxin companies are racing towards the Chinese market. With Hugel, which entered China first,...
Oral Obesity Drug Launched in the U.S.… Where is K-Bio Pharmaceutical Now?

Oral Obesity Drug Launched in the U.S.… Where is K-Bio Pharmaceutical Now?

Denmark's Novo Nordisk's obesity drug ‘Wegovy Pill (ingredient name Semaglutide)’ has recently been launched in the U. S.
SK Bioscience Launches Quadrivalent Meningococcal Vaccine 'MenQuadfi' in Korea

SK Bioscience Launches Quadrivalent Meningococcal Vaccine 'MenQuadfi' in Korea

SK Bioscience announced on the 9th that it has launched the quadrivalent meningococcal conjugate vaccine 'MenQuadfi' in...
Kangstem Biotech, 'Skin Organoid Source Technology' Registered Patent in Japan

Kangstem Biotech, 'Skin Organoid Source Technology' Registered Patent in Japan

Kangstem Biotech's technology related to skin organoids has been granted a patent in Japan.
Temperatures Plunge as Autumn Takes Hold, Shining Spotlight on Red Ginseng for Immune Health

Temperatures Plunge as Autumn Takes Hold, Shining Spotlight on Red Ginseng for Immune Health

As late-summer heat gives way to a sudden autumn chill, public interest in maintaining daily health is rising sharply.
Government Opens Path to Skip 2–3 Years of Clinical Research for Autologous Immune Cell Therapies

Government Opens Path to Skip 2–3 Years of Clinical Research for Autologous Immune Cell Therapies

Some advanced regenerative medicine treatments that culture a patient’s own immune cells and reinfuse them may no...
Internal Radiation Treatment Could Expand Pancreatic Cancer Surgery Options as Samsung Medical Center Partners with Alpha Tau

Internal Radiation Treatment Could Expand Pancreatic Cancer Surgery Options as Samsung Medical Center Partners with Alpha Tau

Pancreatic cancer carries a five-year relative survival rate of just 17.0%, the lowest among all major cancers,...
Why Severe Migraines Could Be the Key to Catching Undiagnosed Endometriosis

Why Severe Migraines Could Be the Key to Catching Undiagnosed Endometriosis

Nearly eight in 10 patients with endometriosis may also suffer from migraines, according to a new analysis revealing...